Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000042033 |
|---|---|
| Receipt number | R000047973 |
| Scientific Title | Special Drug Use-Results Survey for Long-term Use of XEPLION TRI Aqueous Suspension for IM Injection 175 mg, 263 mg, 350 mg, and 525 mg Syringe |
| Date of disclosure of the study information | 2020/12/01 |
| Last modified on | 2024/06/24 13:44:46 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/10/07 10:12:39 | ||
| 2 | Update | 2023/04/11 08:56:57 | Recruitment status Date of IRB |
|
| 3 | Update | 2023/04/11 08:58:48 | Number of participants that the trial has enrolled |
|
| 4 | Update | 2023/04/11 09:05:24 | Address Address Nationality of Funding Organization Organization2 Email2 Organization3 Address3 Tel3 Email3 |
|
| 5 | Update | 2023/10/10 09:07:01 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2024/06/24 13:44:46 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Division name Division name Zip code Address Address TEL Name of person sending information Name of person sending information Organization Division name Division name Address TEL Institute Department Personal name Personal name Organization Division Nationality of Funding Organization Nationality of Funding Organization Organization1 Address1 Tel1 Email1 Organization2 Address2 Tel2 Email2 Organization Address Address Tel |